The Scientist

» bioluminescence and disease/medicine

Most Recent

image: How Predictive are Genomes?

How Predictive are Genomes?

By | April 3, 2012

Researchers put the predictive power of whole genome sequencing to the test.

2 Comments

image: Bird Flu Papers to Publish

Bird Flu Papers to Publish

By | April 2, 2012

Biosecurity board recommends publication of data detailing transmissibility of H5N1 avian influenza.

4 Comments

image: Next Generation: Painless Vaccine Patch

Next Generation: Painless Vaccine Patch

By | April 2, 2012

Vaccination via tiny microneedles elicits a powerful immune response in the skin.

8 Comments

image: Agents Provocateurs

Agents Provocateurs

By | April 1, 2012

Asking pointed questions is a key part of the scientific process.

3 Comments

image: Bushmeat Roulette

Bushmeat Roulette

By | April 1, 2012

Pathogens lurk in illegal wildlife products confiscated at US airports.

12 Comments

Contributors

April 1, 2012

Meet some of the people featured in the April 2012 issue of The Scientist.

0 Comments

image: Antibiotics in the Animals We Eat

Antibiotics in the Animals We Eat

By | April 1, 2012

Low-dose antibiotics in animal feed fuel drug-resistance in human infectious diseases.

0 Comments

image: Are Cancer Stem Cells Ready for Prime Time?

Are Cancer Stem Cells Ready for Prime Time?

By | April 1, 2012

A flood of new discoveries has refined our definition of cancer stem cells. Now it’s up to human clinical trials to test if they can make a difference in patients.

48 Comments

Deliberating Over Danger

By | April 1, 2012

The creation of H5N1 bird flu strains that are transmissible between mammals has thrown the scientific community into a heated debate about whether such research should be allowed and how it should be regulated.

16 Comments

image: Eyes on Cancer

Eyes on Cancer

By | April 1, 2012

Techniques for watching tumors do their thing

4 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham